Literature DB >> 12225338

Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy.

Nobuo Tsuru1, Yutaka Kurita, Hiroaki Masuda, Kazuo Suzuki, Kimio Fujita.   

Abstract

BACKGROUND: The aim of the present study was to assess the resistive index in patients with benign prostatic hypertrophy (BPH) and the role of power Doppler ultrasonography.
METHODS: From April 1996 to December 1997, a total of 214 men aged 48-86 years with symptoms of BPH were prospectively enrolled to participate in our study. All patients presented to our clinic with lower urinary tract symptoms. Transrectal ultrasonography was used to calculate the total prostate volume (TPV), transition zone (TZ) volume, transition zone index (TZI = TZ volume/TPV) and presumed circle area ratio (PCAR). Power Doppler imaging was used to identify the capsular and urethral arteries of the prostate and measure its resistive index (RI) value.
RESULTS: The RI of capsular arteries significantly correlated with theTPV, TZ volume, TZI (r = 0.470; P < 0.0001) and PCAR (r = 0.334; P < 0.0001). Correlations were found between the RI of capsular arteries and the International Prostatic Symptom Score (IPSS) (r = 0.389; P < 0.0001), peak flow rate of uroflowmetry (r = -0.393; P < 0.0001).
CONCLUSION: We demonstrated that an increase of the RI of capsular arteries correlated with increases in the TZI and PCAR in BPH. The lower IPSS and peak flow rate correlated with the high RI of capsular arteries; however, no correlation between the RI of urethral arteries and prostatic parameters was found. The findings suggested that the RI of capsular arteries may become the index for measuring lower urinary obstruction in the future.

Entities:  

Mesh:

Year:  2002        PMID: 12225338     DOI: 10.1046/j.1442-2042.2002.00494.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  7 in total

Review 1.  Tadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of action.

Authors:  Osamu Yokoyama; Yasuhiko Igawa; Masayuki Takeda; Takafumi Yamaguchi; Masahiro Murakami; Lars Viktrup
Journal:  Ther Adv Urol       Date:  2015-10

Review 2.  Application of ultrasonography and the resistive index for evaluating bladder outlet obstruction in patients with benign prostatic hyperplasia.

Authors:  Hitoshi Shinbo; Yutaka Kurita
Journal:  Curr Urol Rep       Date:  2011-08       Impact factor: 3.092

3.  Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Authors:  A P Berger; M Deibl; E J Halpern; M Lechleitner; J Bektic; W Horninger; G Fritsche; H Steiner; A Pelzer; G Bartsch; F Frauscher
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

4.  Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP).

Authors:  Huan Xu; Chong Liu; Meng Gu; Yanbo Chen; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Oncotarget       Date:  2017-02-21

5.  B-Mode and Doppler Ultrasonographic Findings of Prostate Gland and Testes in Dogs Receiving Deslorelin Acetate or Osaterone Acetate.

Authors:  Wojciech Niżański; Małgorzata Ochota; Christelle Fontaine; Joanna Pasikowska
Journal:  Animals (Basel)       Date:  2020-12-11       Impact factor: 2.752

6.  Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia.

Authors:  Se Yun Kwon; Jung Woo Ryu; Dai Hai Choi; Kyung Seop Lee
Journal:  Int Neurourol J       Date:  2016-03-14       Impact factor: 2.835

7.  Transrectal Doppler Sonography of Benign Prostatic Enlargement in Nigerian Men.

Authors:  Olubukola Olayinka Fanimi; Christianah Mopelola Asaleye; Abdulkadir Ayo Salako; Oluwagbemiga Oluwole Ayoola; Tewogbade Adeoye Adedeji; Bukunmi Michael Idowu
Journal:  J Med Ultrasound       Date:  2019-05-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.